Sort
64,565 grants matching “drug discovery”
Novel antifungal agents against coccidioidomycosis
$747,858Maciej Walczak · University Of Colorado · R01 · FY2024 · AI
Massively Parallel Identification of Protein Ligands
$747,843Benjamin F Cravatt · Scripps Research Institute, The · R01 · FY2012 · GM
Chemical probes of vulnerable pathways in antibiotic-resistant pathogens
$747,835Tanya Parish · Access To Advanced Health Institute · R01 · FY2012 · AI
Near-IR Photorelease Chemistry: Discovery and Applications
$747,771Martin Schnermann · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Development of Novel Proteins Synthesis Inhibitors for MDR Tuberculosis
$747,745Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2022 · AI
Fully-Automated Lesion Characterization in Ultrawide-Field Retinal Images
$747,733Sandeep Bhat · Eyenuk, Inc. · R44 · FY2021 · EY
Multimarker Risk Prediction in Cancer Therapy Cardiotoxicity
$747,668Bonnie Ky · University Of Pennsylvania · R01 · FY2015 · HL
Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents
$747,535Terrence Burke · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Faculty Recruitment in Novel Therapeutic Strategies for Neurodegenerative Disease
$747,500Raymond J Dingledine · Emory University · P30 · FY2010 · NS
Biological Magnetic Resonance Data Bank
$747,399Jeffrey C Hoch · University Of Connecticut Sch Of Med/Dnt · R24 · FY2024 · GM
Inhibiting poxvirus phosphatases: therapy and biodefense
$747,388Medical College Of Wisconsin · U01 · FY2004 · AI
QCIS-FF: Quantum Computing & Information Science Faculty Fellow at North Carolina State University
$747,273Veena Misra · North Carolina State University · · FY2021 · CSE
Mechano-chemical regulation of the microenvironmental niche in melanoma
$747,231Kandice Tanner · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Blocking a novel cytokine signaling pathway for the treatment of rheumatoid arthr
$747,226Kirill Ostanin · Navigen, Inc. · R44 · FY2014 · AR
Massively Parallel Identification of Protein Ligands
$747,193Benjamin F Cravatt · Scripps Research Institute, The · R01 · FY2011 · GM
Subtype-selective phosphodiesterase PET ligands
$747,136Steven H Liang · Emory University · R01 · FY2025 · AG
Antibody Therapy of Cancer
$747,016Mitchell Ho · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
A fluorescent reporter detecting precise homologous recombination transgenesis activity
$747,005Trisha Brock · Kdt, Inc · R44 · FY2017 · HD
Nqo2 in Primaquine-Induced Hemolysis of G6PD-deficient RBCs
$746,958James C. Zimring · University Of Virginia · R01 · FY2024 · HL
Novel therapeutics for FSHD
$746,947Charles P Emerson · Univ Of Massachusetts Med Sch Worcester · P50 · FY2023 · HD
Macromolecular Conformational Heterogeneity
$746,909Alexander D. Mackerell · University Of Maryland Baltimore · R35 · FY2024 · GM
Macromolecular Conformational Heterogeneity
$746,909Alexander D. Mackerell · University Of Maryland Baltimore · R35 · FY2025 · GM
Development and Testing of Hsp90 Inhibitors
$746,857Leonard Petrucelli · Mayo Clinic Jacksonville · U01 · FY2010 · NS
Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress
$746,835Christopher D Willey · University Of Alabama At Birmingham · U01 · FY2019 · CA
Commercialization of a rapid, automated Hi-C platform for sensitive genomic profiling of multiple cancer sample types
$746,680Elizabeth Munding · Cantata Bio Llc · R44 · FY2025 · HG